TY - JOUR
T1 - Risk factors for 30-day perioperative complications after le Fort colpocleisis
AU - Catanzarite, Tatiana
AU - Rambachan, Aksharananda
AU - Mueller, Margaret G.
AU - Pilecki, Matthew A.
AU - Kim, John Y.S.
AU - Kenton, Kimberly
PY - 2014/9
Y1 - 2014/9
N2 - Purpose We identified rates of and risk factors for complications after colpocleisis using the American College of Surgeons NSQIP® database. Materials and Methods Women treated with Le Fort colpocleisis from 2005 to 2011 were identified in the database. Primary outcomes were 30-day complication rates. Secondary outcomes were risk factors for complications and the impact of age and a concomitant sling on morbidity. Clinical and procedural characteristics were compared using the chi-square test and 1-way ANOVA. Results We identified 283 women, of whom 23 (8.1%) experienced complications. The most common complication was urinary tract infection in 18 women (6.4%). There was 1 death for a 0.4% mortality rate. Increased complications were associated with age less than 75 years (p = 0.03), chronic obstructive pulmonary disease (p = 0.03), hemiplegia (p = 0.03), disseminated cancer (p = 0.03) and open wound infection (p = 0.02). Six patients (2.1%) required return to the operating room within 30 days. Complication rates did not differ based on operative time (p = 0.78), inpatient status (p = 0.24), resident involvement (p = 0.35), concomitant sling placement (p = 0.81) or anesthesia type (p = 0.27). Women undergoing colpocleisis without (191) and with (92) a sling had similar baseline characteristics. Colpocleisis without and with a sling had similar rates of complications (7.9% vs 8.7%, p = 0.81), urinary tract infection (5.8% vs 7.6%, p = 0.55), return to the operating room (2.1% vs 2.2%, p = 0.97) and mortality (0% vs 1.1%, p = 0.15). Conclusions Mortality and complication rates after colpocleisis are low with urinary tract infection being the most common postoperative complication. Concomitant sling placement does not increase 30-day complication rates.
AB - Purpose We identified rates of and risk factors for complications after colpocleisis using the American College of Surgeons NSQIP® database. Materials and Methods Women treated with Le Fort colpocleisis from 2005 to 2011 were identified in the database. Primary outcomes were 30-day complication rates. Secondary outcomes were risk factors for complications and the impact of age and a concomitant sling on morbidity. Clinical and procedural characteristics were compared using the chi-square test and 1-way ANOVA. Results We identified 283 women, of whom 23 (8.1%) experienced complications. The most common complication was urinary tract infection in 18 women (6.4%). There was 1 death for a 0.4% mortality rate. Increased complications were associated with age less than 75 years (p = 0.03), chronic obstructive pulmonary disease (p = 0.03), hemiplegia (p = 0.03), disseminated cancer (p = 0.03) and open wound infection (p = 0.02). Six patients (2.1%) required return to the operating room within 30 days. Complication rates did not differ based on operative time (p = 0.78), inpatient status (p = 0.24), resident involvement (p = 0.35), concomitant sling placement (p = 0.81) or anesthesia type (p = 0.27). Women undergoing colpocleisis without (191) and with (92) a sling had similar baseline characteristics. Colpocleisis without and with a sling had similar rates of complications (7.9% vs 8.7%, p = 0.81), urinary tract infection (5.8% vs 7.6%, p = 0.55), return to the operating room (2.1% vs 2.2%, p = 0.97) and mortality (0% vs 1.1%, p = 0.15). Conclusions Mortality and complication rates after colpocleisis are low with urinary tract infection being the most common postoperative complication. Concomitant sling placement does not increase 30-day complication rates.
KW - aged
KW - gynecologic surgical procedures
KW - postoperative complications
KW - urinary tract
KW - uterine prolapse
UR - http://www.scopus.com/inward/record.url?scp=84906096227&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84906096227&partnerID=8YFLogxK
U2 - 10.1016/j.juro.2014.03.040
DO - 10.1016/j.juro.2014.03.040
M3 - Article
C2 - 24641911
AN - SCOPUS:84906096227
SN - 0022-5347
VL - 192
SP - 788
EP - 792
JO - Journal of Urology
JF - Journal of Urology
IS - 3
ER -